Publicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (15)

2021

  1. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2014

  1. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations

    Revista Iberoamericana de Micologia, Vol. 31, Núm. 3, pp. 157-175

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study

    Transplant International, Vol. 25, Núm. 12, pp. 1275-1281

2011

  1. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  2. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica

2010

  1. Immunosuppressive therapy and infection after kidney transplantation

    Transplant Infectious Disease, Vol. 12, Núm. 5, pp. 397-405

2009

  1. Consensus document for the management of tuberculosis in solid organ transplant recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 8, pp. 465-473

  2. Tuberculosis in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in transplant recipients (GESITRA) of the Spanish society of infectious diseases and clinical microbiology

    Clinical Infectious Diseases, Vol. 48, Núm. 9, pp. 1276-1284

2008

  1. Donor infection and transmission to the recipient of a solid allograft

    American Journal of Transplantation, Vol. 8, Núm. 11, pp. 2420-2425

2007

  1. Bloodstream infections among transplant recipients: Results of a nationwide surveillance in Spain

    American Journal of Transplantation, Vol. 7, Núm. 11, pp. 2579-2586

2005

  1. Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus in transplanted patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 7, pp. 424-437

  2. Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study

    Clinical Infectious Diseases, Vol. 41, Núm. 1, pp. 52-59